Posted: Thursday, February 1, 2024
Nikhil Khushalani, MD, of H. Lee Moffitt Cancer Center and Research Institute, surveys treatment advances in Merkel cell, cutaneous squamous cell, basal cell, and other non-melanoma skin cancers as well as therapies under study that are most likely to affect patients in 2024.